Skip to main content
OpenTrials
Completed

NCT Number: NCT04670003

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases.

Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut Interrégional de Cancérologie

Le Mans, 72000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • users of the application
  • not having objected to the use of their data

Exclusion criteria

  • user who does not have a complete questionnaire

Treatment and study plan

users

Other

Data of users of the web-application

Primary outcomes

  1. Description of the methods of contamination of patients

    Time frame: 2 months

    Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)

Secondary outcomes

  1. Evaluation in time of the spread of the virus during the 2nd epidemic wave.

    Time frame: 2 months

    Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)

  2. Evaluation in space of the spread of the virus during the 2nd epidemic wave.

    Time frame: 2 months

    Data and symptomes collected by the web applications self-questionnaire according to ZIP code (patient reported outcome)

Sponsors and collaborators

Lead sponsor

Weprom

Other

Collaborators

  • Kelindi

Registry information

Official study title

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study

Acronym: SourceCOVID

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Dec 17, 2020
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.